To analyse chemokine receptor expression by FACS, cells were incubated first with blocking solution (mouse serum in PBS) during 20 minutes, followed by a second incubation with a biotinylated mouse anti-CCR9 antibody (1
μg/10
6 cells) (eBioscience, CA, USA) in FACS buffer (PBS containing 2% fetal bovine serum and 0.1% NaN
3) for 30 min at 4°C. Finally cells were incubated with a solution of streptavidin-APC or streptavidin-PerCP during 30 min at 4°C in the dark.
For phenotypic detection of other cell populations, single cell suspensions were preincubated with a mixture of
anti-CD16/CD32 antibodies (BioLegend, CA, USA) during 10 min at room temperature. Following first incubation and several washes, cells were incubated with either
anti-CD4-PeCy7,
anti-CD8-PE,
anti-Gr1-PeCy5 (BioLegend, CA, USA), or anti-Siglec (BD, CA, USA) antibodies in FACS buffer for 30 min at 4°C (according to manufacturer's suggestions). Finally, samples were analyzed in
Attune® Acoustic flow cytometer (Life Technologies, Thermo Fisher Scientific, MA, USA). Analysis of data was performed with FlowJo 8.7 software (Tree Star, Inc.).
López-Pacheco C., Soldevila G., Du Pont G., Hernández-Pando R, & García-Zepeda E.A. (2016). CCR9 Is a Key Regulator of Early Phases of Allergic Airway Inflammation. Mediators of Inflammation, 2016, 3635809.